August 19, 2008 - Dräger Medical Inc. today said its Fabius MRI anesthesia machine received FDA clearance, and is designed specifically to meet the requirements for the magnetic resonance imaging (MRI) environment.

The Fabius MRI is designed for use with 1.5T and 3.0T MRI systems. An integrated Teslameter provides an acoustic alarm if the Fabius MRI is positioned within a field-strength greater than 40mTesla (400 Gauss).

The Fabius MRI employs the same user interface as Dräger’s Fabius GS, Fabius Tiro and Apollo machines, creating a uniform and consistent interface for the anesthesia provider wherever anesthesia is required. The size of the MRI system often requires the anesthesia provider to be outside the room or some distance away from the device during an examination. To accommodate this, the company said additional optical alarm displays (LEDs) at the top of the system provide visual indication for all alarm conditions for the safety of the patient in this specialized environment.

Dräger said the Fabius MRI has the same standards as those used in the OR application. The standard configuration includes the advanced ventilation modes (volume and pressure controlled, pressure support and SIMV) that are especially needed for the care of premature infants, newborns, and ICU patients. A high-speed piston ventilator provides controlled compliance compensation, even with the longer ventilation tubes often used in the MRI environment, providing even for the smallest infant.

Dräger also offers a range of MRI-compatible accessories, all tested and certified for use with the Fabius MRI machine.

For more information: www.draeger.com


Related Content

News | Pediatric Imaging

April 10, 2025 — Cincinnati Children’s and GE HealthCare will form a strategic research program focused on driving ...

Time April 10, 2025
arrow
News | Radiology Imaging

Jan. 15, 2025 — University of California, San Francisco (UCSF) Department of Radiology & Biomedical Imaging and GE ...

Time January 27, 2025
arrow
News | Contrast Media

Jan. 10, 2025 – Bayer has announced positive topline results of the Phase III QUANTI studies evaluating the efficacy and ...

Time January 14, 2025
arrow
News | Women's Health

Aug. 19, 2024 — GE HealthCare recently announced a collaboration with the University of California San Diego School of ...

Time August 29, 2024
arrow
News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 23, 2024 — Researchers at the National Institutes of Health (NIH) found that an artificial intelligence (AI) model ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 17, 2024 — Hyperfine, a groundbreaking medical device company that has redefined brain imaging with the world’s ...

Time July 17, 2024
arrow
News | Prostate Cancer

July 11, 2024 — GE HealthCare’s MIM Software, a global provider of medical imaging analysis and artificial intelligence ...

Time July 11, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
Subscribe Now